MON is flat today. Investors presumably don't think having the Bayer and MON CEOs pitching the deal to Trump makes any difference vis-á-vis the probability of getting regulatory approval from 30 countries.
Thanks for the post.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.